Expression of Vascular Endothelial Growth Factor mRNA in Ovarian Neoplasm and Its Clinical Significance

doi:10.3877/cma.j.issn.1673-5250.2011.02.006

Objective

To investigate the expression of subtypes of vascular endothelial growth factor (VEGF) mRNA in ovarian neoplasm and its clinical significance.

Methods

From January 2000 to June 2004, tumor samples from 54 cases (research group) of ovarian malignant tumor were recruited into this study. Among them, ovarian epithelial carcinoma was 41 cases, and non-epithelial carcinoma was 13 (control group). The expressions of VEGF mRNA subtypes in ovarian malignant tumor and controls were detected by reverse transcriptase-polymerase chain reaction (RT-PCR). Meanwhile, an antibody to von willebrand factor (F8) was used to detect tumor microvessel density (MVD). The study protocol was approved by Beijing General Army Hospital. Informed consent was obtained from all participants.

Results

①The expression positive rates of VEGF 121, VEGF 165 in ovarian malignant were significantly higher than those in benign tumor and normal control (P<0.05); VEGF 189 were only expressed in ovarian malignant. ②No significantly association were between expressive levels of VEGF mRNA subtypes and clinical stage (χ²=0.259, P>0.05). ③The positive expression rate of VEGF 189 in patients with lymph node metastasis and omentum involvement were significantly higher than those in non-lymph node metastasis and normal omentum (P<0.05). ④There was a close relationship between VEGF 189 expression and microvessel density in ovarian malignant (P=0.003).

Conclusion

The expression of VEGF 121, 165 were correlated with the carcinogenesis and progress of ovarian malignant. VEGF 189 might be a biomarker for the status of ovarian carcinomas present in invasion and metastasis. VEGF 189 plays an important role in the angiogenesis of ovarian malignant.

Key words: vascular endothelial growth factor (VEGF), microvessel density (MVD), ovarian neoplasm, invasion, metastasis

图1　卵巢组织VEGF mRNA亚型表达聚丙烯酰胺凝胶银染电泳结果(lane1：对照组2(正常卵巢)仅表达VEGF 121; lane 2，4：恶性肿瘤，可见VEGF 121，165和189 3条带，VEGF 189呈弱表达；lane 3：对照组1(良性肿瘤), 可见VEGF 165，121表达2条带；lane 5 ：阴性对照；lane 6 ：100 bp DNAMarker; lane 7: 阳性对照)

图2　卵巢恶性肿瘤组织VEGF mRNA亚型表达聚丙烯酰胺凝胶银染电泳结果(lane 1，3: 无淋巴结转移卵巢恶性肿瘤组织；lane 2，6 ：阴性对照；lane 4，10：大网膜正常卵巢恶性肿瘤组织；lane 5：淋巴结转移卵巢恶性肿瘤组织；lane 7：大网膜转移卵巢恶性肿瘤组织可见VEGF 121，165和189表达3条带；lane 8 ：阳性对照；lane 9: 100 bp DNAMarker.)

图3　VEGF 189表达呈阳性的卵巢恶性肿瘤组织MVD: 镜下(×100)见微血管丰富，可见毛细血管簇及裂隙状血管(以F8为血管内皮细胞的标记物，SABC法染色测定卵巢恶性肿瘤组织MVD)

图4　VEGF表达呈阴性卵巢恶性肿瘤组织MVD：镜下(×100)见微血管稀疏(以F8为血管内皮细胞的标记物，SABC法染色卵巢恶性肿瘤组织MVD)

	1　Fujimoto J, Sakaguchi H, Hirose R, et al. Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma [J]. Cancer, 1998, 83(12): 2528-2533.
	2　Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. [J]. J Natl Cancer Inst, 1992, 84(24): 1875-1887.
	3　Boocock CA, Charnock-Jones DS, Sharkey AM, et al. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma [J]. J Natl Cancer Inst, 1995, 87(7): 506-516.
	4　Shen GH, Ghazizadeh M, Kawanami O, et al. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma [J]. Br J Cancer, 2000, 83(2): 196-203.
	5　Paley PJ, Staskus KA, Gebhard K, et al. Vascular endothelial growth factor expression in early stage ovarian carcinoma [J]. Cancer, 1997, 80(1): 98-106.
	6　Takayama K, Ueno H, Nakanishi Y, et al. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ [J]. Cancer Res, 2000, 60(8): 2169-2177.
	7　Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice [J]. Nature, 1995, 376(6535): 62-66.
	8　Tsurusaki T, Kanda S, Sakai H, et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis [J]. Br J Cancer, 1999, 80(1-2): 309-313.

[1]	Miao Li, Lianhua Zhu, Peng Han, Bo Jiang, Xiang Fei. Evaluation of relationsip between vascular morphology and risk factors for hepatocellular carcinoma by high-frame-rate contrast-enhanced ultrasound[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(09): 911-915.
[2]	Guo Sun, Yingdong Xie, Chaoli Xu, Bin Yang. Clinical value of a nomogram based on ultrasonic and clinical features for predicting central and lateral cervical lymph node metastases of thyroid papillary carcinoma[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(07): 734-742.
[3]	Xia Kang, Hao Tian, Jin Qian, Yuan Gao, Hongming Miao, Xiaowei Qi. Osteorin attenuates osteolysis during bone metastasis of cancers through inhibiting osteoclastogenesis[J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 329-339.
[4]	Xiongxiong Li, Chan Zhou, Ting Xu, Yu Ren, Jin Shang. Metastasis rate of newly diagnosed ductal carcinoma in situ with microinvasive axillary lymph nodes: A Meta-analysis[J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 466-474.
[5]	Xu Tang, Bing Han, Wei Liu, Ruxing Chen. Analysis of risk factors for metachronous liver metastases after radical colorectal cancer surgery and construction of a predictive model[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 16-20.
[6]	Yutao Yuan, Jinlin Xing, Kefei Xie, Kai Yin. Correlation between CT findings and BRAF^V600E gene mutation and central lymph node metastasis in papillary thyroid carcinoma[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 611-614.
[7]	Qingyan Yan, Xiaomei Yong, Hong Luo, Min Du. Prognostic factors and survival analysis of multicenter elderly patients with metastatic breast cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 636-638.
[8]	Cheng Xu, Lulu Wang, Shaohua Wang. Application of eluent thyroglobulin in metastatic lymph nodes of thyroid papillary carcinoma[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 701-704.
[9]	Jian Chang, Feng Qiu, Yuqi Mao. Analysis of the relationship between ingestion inhibition factor-1 and liver metastasis after laparoscopic radical resection of colorectal cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 502-505.
[10]	Xiaoyan Wang, You Xiao, Ge Xiao, Zhenquan Wang. CT characteristics and risk factors of lung metastasis in elderly patients with colorectal cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 506-509.
[11]	Qing Yan, Ying Liu, Feiwen Deng, Huanwei Chen. Effect of microvascular invasion on survival and prognosis of liver transplantation recipients with liver cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 624-629.
[12]	Bing Lan, Huaiming Wang, Hui Wang, Bo Ma. Research progress on locally advanced colon cancer with bladder invasion[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 505-511.
[13]	Hongjie Yang, Zhichun Zhang, Yi Sun. Study progress in the diagnosis of lymph node metastasis of rectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 512-518.
[14]	Yicheng Huang, Chen Lu, Sizheng Sun, Chunzhao Yu. Expression of liver-specific transcription factors FOXA2 in human stepwise metastatic colorectal carcinoma model and its significance[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(05): 396-403.
[15]	Qi Liu, Kai Zhang, Jiannan Li, Tongjun Liu. Current status and progress of biologic treatment for colorectal cancer liver metastases[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(05): 415-419.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export